Studies indicate that Providence Medical Technology’s tissue-sparing DTRAX® Expandable Cage and CAVUX® Cervical Cages yielded improvements in pain, with radiographic confirmation of fusion.
The first study results indicated that posterior cervical transfacet fusion is a safe and effective procedure to treat single-level cervical radiculopathy. This study represented the first ever prospective, randomized, controlled trial comparing results using DTRAX vs. traction. The study presents data on 40 patients from each group.
The second study addressed use of bilateral posterior cervical fusion cages to treat anterior cervical pseudarthrosis. At 18 months, fusion was confirmed radiographically in all 25 patients.
The DTRAX Expandable Cage System is approved under the CE Mark, while the CAVUX cage is CE Mark Approved and FDA 510(k) cleared.
Studies indicate that Providence Medical Technology's tissue-sparing DTRAX® Expandable Cage and CAVUX® Cervical Cages yielded improvements in pain, with radiographic confirmation of fusion.
The first study results indicated that posterior cervical transfacet fusion is a safe and effective procedure to treat single-level cervical...
Studies indicate that Providence Medical Technology’s tissue-sparing DTRAX® Expandable Cage and CAVUX® Cervical Cages yielded improvements in pain, with radiographic confirmation of fusion.
The first study results indicated that posterior cervical transfacet fusion is a safe and effective procedure to treat single-level cervical radiculopathy. This study represented the first ever prospective, randomized, controlled trial comparing results using DTRAX vs. traction. The study presents data on 40 patients from each group.
The second study addressed use of bilateral posterior cervical fusion cages to treat anterior cervical pseudarthrosis. At 18 months, fusion was confirmed radiographically in all 25 patients.
The DTRAX Expandable Cage System is approved under the CE Mark, while the CAVUX cage is CE Mark Approved and FDA 510(k) cleared.
Copy to clipboard 
